Loading organizations...
Cigalah Group operates as a prominent distribution and marketing powerhouse, specializing in a comprehensive portfolio of pharmaceutical, personal healthcare, and consumer products across various sectors. The company leverages an extensive sales force and sophisticated logistics to ensure wide market penetration, effectively increasing market share for its diverse range of international partners and principals. Its operational framework prioritizes lean processes, high-quality offerings, skilled personnel, and enhanced productivity to maintain a competitive edge.
The origins of Cigalah Group trace back to 1911 when Mohamed Abdul Wahab Naghi initiated the family's active engagement in consumer and trading businesses. The Naghi family has since cultivated over a century of profound expertise in the pharmaceutical and consumer product sectors within the Kingdom. From the late 1980s, under the leadership of Yaser Yousuf Naghi, the group expanded significantly, evolving into its current extensive corporate structure.
Cigalah Group serves a broad customer base, encompassing wholesale and retail outlets, over 8,000 pharmacies, Governmental Officials, and Healthcare Professionals. The company is committed to achieving market leadership through operational excellence, delivering superior quality and service, and driving innovation in pharmaceutical distribution. Its long-term vision centers on establishing a solid reputation for customer satisfaction, profitability, and performance across all its diversified activities.
Cigalah Group has 1 tracked investment across 1 company. The latest tracked deal is $7.0M Pre-Series A in Aumet in March 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 20, 2023 | Aumet | $7.0M Pre-Series A | — | AAIC, AIJ Holdings, Hamid ALI Sagri Family Office, Shorooq Partners, Tijah Holdings |